Xu Wang

3.2k total citations
122 papers, 2.3k citations indexed

About

Xu Wang is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Xu Wang has authored 122 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 28 papers in Oncology and 14 papers in Surgery. Recurrent topics in Xu Wang's work include RNA modifications and cancer (8 papers), Cancer-related Molecular Pathways (7 papers) and Nanoplatforms for cancer theranostics (7 papers). Xu Wang is often cited by papers focused on RNA modifications and cancer (8 papers), Cancer-related Molecular Pathways (7 papers) and Nanoplatforms for cancer theranostics (7 papers). Xu Wang collaborates with scholars based in China, United States and Japan. Xu Wang's co-authors include Wantao Chen, Ming Yan, Qin Xu, Jianjun Zhang, Wei Cao, Xing Qin, Juan Ni, Tong Ji, Wantao Chen and Yun Guo and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Xu Wang

115 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xu Wang China	27	1.0k	356	343	304	195	122	2.3k
Ji‐Young Lee South Korea	26	1.1k 1.0×	422 1.2×	243 0.7×	445 1.5×	189 1.0×	79	2.8k
Xue Wang China	28	968 0.9×	381 1.1×	219 0.6×	309 1.0×	112 0.6×	148	2.1k
Ning Liu China	31	1.3k 1.3×	494 1.4×	413 1.2×	181 0.6×	152 0.8×	189	3.0k
Yingchun Zhao China	29	1.1k 1.1×	514 1.4×	356 1.0×	272 0.9×	296 1.5×	125	2.5k
Yingjie Xu China	26	1.7k 1.7×	395 1.1×	312 0.9×	231 0.8×	218 1.1×	92	2.8k
Ting Zhao China	26	865 0.8×	231 0.6×	239 0.7×	169 0.6×	226 1.2×	141	2.2k
Jingjing Zhang China	33	1.4k 1.4×	476 1.3×	254 0.7×	188 0.6×	190 1.0×	194	3.3k
Weijun Wu China	28	1.1k 1.0×	300 0.8×	184 0.5×	223 0.7×	98 0.5×	70	2.3k
Xiaoli Ma China	30	1.7k 1.6×	515 1.4×	521 1.5×	226 0.7×	191 1.0×	139	3.0k

Countries citing papers authored by Xu Wang

Since Specialization

Citations

This map shows the geographic impact of Xu Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xu Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xu Wang more than expected).

Fields of papers citing papers by Xu Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xu Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xu Wang. The network helps show where Xu Wang may publish in the future.

Co-authorship network of co-authors of Xu Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Xu Wang. A scholar is included among the top collaborators of Xu Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xu Wang. Xu Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Xu, Jiang Li, Chengkai Zhang, et al.. (2025). Old players and new insights: unraveling the role of RNA-binding proteins in brain tumors. Theranostics. 15(11). 5238–5257. 3 indexed citations

Dos’Santos, Thomas, et al.. (2025). Is There a Performance‐Injury Conflict Between Maximum Horizontal Deceleration and Surrogates of Noncontact Anterior Cruciate Ligament Injury?. European Journal of Sport Science. 25(8). e70014–e70014.

Wang, Xu, Yayin Lu, Lijuan Cao, et al.. (2025). Lead biosorption by Bacillus tequilensis FB‐6: characterization of resistance mechanisms and its potential for remediation of contaminated soil. Journal of the Science of Food and Agriculture. 105(13). 7095–7102.

Hu, Xin, Mi Zhang, Zhihui Li, et al.. (2025). Targeting CXCL8 signaling sensitizes HNSCC to anlotinib by reducing tumor-associated macrophage-derived CLU. Journal of Experimental & Clinical Cancer Research. 44(1). 39–39. 2 indexed citations

Zhan, Lei, Xiangyun Yao, Xiangyang Wang, et al.. (2025). Piezoelectric Polyvinylidene Fluoride-Trifluoroethylene/Reduced Graphene Oxide/Polycaprolactone Fiber Material: Modulating Neutrophil Extracellular Traps and Reshaping the Immune Microenvironment in Peripheral Nerves. Advanced Fiber Materials. 7(2). 645–663. 3 indexed citations

Zhou, Ping, et al.. (2024). Identification of biomarkers related to tryptophan metabolism in osteoarthritis. Biochemistry and Biophysics Reports. 39. 101763–101763. 5 indexed citations

Wang, Xu, Yuqing Zhang, Liheng Liu, et al.. (2024). Prognostic and Immunotherapeutic Predictive Value of CAD Gene in Hepatocellular Carcinoma: Integrated Bioinformatics and Experimental Analysis. Molecular Biotechnology. 67(3). 1240–1255. 2 indexed citations

Fan, Lili, et al.. (2023). GRC-Net: Fusing GAT-Based 4D Radar and Camera for 3D Object Detection. SAE International Journal of Advances and Current Practices in Mobility. 6(5). 2690–2696. 6 indexed citations

Wang, Xu, et al.. (2023). Improving Vulnerability Detection with Hybrid Code Graph Representation. 11. 259–268. 1 indexed citations

10.

Han, Chang Yeop, Xu Wang, Alexander E. St. John, et al.. (2023). A novel melanocortin fusion protein inhibits fibrinogen oxidation and degradation during trauma-induced coagulopathy. Blood. 142(8). 724–741. 5 indexed citations

11.

He, Ping, Fengyi Liu, Mingxing Ren, et al.. (2023). Mitochondrial Calcium Ion Nanogluttons Alleviate Periodontitis via Controlling mPTPs. Advanced Healthcare Materials. 12(15). e2203106–e2203106. 28 indexed citations

12.

Fan, Lili, et al.. (2023). Voxel Density-based Point Cloud Masked Auto-Encoder Loss Function. 1–5. 2 indexed citations

13.

Han, Chang Yeop, et al.. (2022). Leukocyte activation primes fibrinogen for proteolysis by mitochondrial oxidative stress. Redox Biology. 51. 102263–102263. 18 indexed citations

14.

Li, Fan, Yan Liang, Xing Xu, et al.. (2021). Multifunctional nanoplatforms as cascade-responsive drug-delivery carriers for effective synergistic chemo-photodynamic cancer treatment. Journal of Nanobiotechnology. 19(1). 140–140. 20 indexed citations

15.

Jiang, Shu‐Heng, Yahui Wang, Li-Peng Hu, et al.. (2021). The physiology, pathology and potential therapeutic application of serotonylation. Journal of Cell Science. 134(11). 20 indexed citations

16.

Cheng, Junfei, Yu Li, Xu Wang, Guoqiang Dong, & Chunquan Sheng. (2020). Discovery of Novel PDEδ Degraders for the Treatment of KRAS Mutant Colorectal Cancer. Journal of Medicinal Chemistry. 63(14). 7892–7905. 57 indexed citations

17.

Qin, Xing, Ming Yan, Xu Wang, et al.. (2018). Cancer-associated Fibroblast-derived IL-6 Promotes Head and Neck Cancer Progression via the Osteopontin-NF-kappa B Signaling Pathway. Theranostics. 8(4). 921–940. 141 indexed citations

18.

Wang, Xu, Wei Cao, Jianjun Zhang, et al.. (2017). A covalently bound inhibitor triggers EZH 2 degradation through CHIP ‐mediated ubiquitination. The EMBO Journal. 36(9). 1243–1260. 74 indexed citations

19.

Li, Huiying, Linhua Zhao, Bo Zhang, et al.. (2014). A Network Pharmacology Approach to Determine Active Compounds and Action Mechanisms of Ge‐Gen‐Qin‐Lian Decoction for Treatment of Type 2 Diabetes. Evidence-based Complementary and Alternative Medicine. 2014(1). 495840–495840. 150 indexed citations

20.

Wang, Xu. (2007). Impacts of Folic Acid,Riboflavin Deficiency and MTHFR A1298C Polymorphism on Human Lymphocytes Genomic Stability. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact